Search

Gary W. Counts

Examiner (ID: 5481, Phone: (571)272-0817 , Office: P/1678 )

Most Active Art Unit
1678
Art Unit(s)
1641, 1678, 1677
Total Applications
1282
Issued Applications
604
Pending Applications
186
Abandoned Applications
499

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17721643 [patent_doc_number] => 20220214365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => Methods of Detecting Anti-folic acid Antibodies and Uses Thereof [patent_app_type] => utility [patent_app_number] => 17/699706 [patent_app_country] => US [patent_app_date] => 2022-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16088 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699706 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/699706
Methods of detecting anti-folic acid antibodies and uses thereof Mar 20, 2022 Issued
Array ( [id] => 19061224 [patent_doc_number] => 11940450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-26 [patent_title] => Biomarker panel for non-invasive diagnosis of congenital renal dysfunction [patent_app_type] => utility [patent_app_number] => 17/695381 [patent_app_country] => US [patent_app_date] => 2022-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 8368 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695381 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/695381
Biomarker panel for non-invasive diagnosis of congenital renal dysfunction Mar 14, 2022 Issued
Array ( [id] => 17706009 [patent_doc_number] => 20220206015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => MARKER FOR STATIN TREATMENT STRATIFICATION IN HEART FAILURE [patent_app_type] => utility [patent_app_number] => 17/693789 [patent_app_country] => US [patent_app_date] => 2022-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28674 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17693789 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/693789
MARKER FOR STATIN TREATMENT STRATIFICATION IN HEART FAILURE Mar 13, 2022 Abandoned
Array ( [id] => 17674157 [patent_doc_number] => 20220187324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => MULTIPLEXED DIAGNOSTIC TO RECOGNIZE CONCENTRATIONS OF RELATED PROTEINS AND PEPTIDES [patent_app_type] => utility [patent_app_number] => 17/684296 [patent_app_country] => US [patent_app_date] => 2022-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12072 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17684296 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/684296
MULTIPLEXED DIAGNOSTIC TO RECOGNIZE CONCENTRATIONS OF RELATED PROTEINS AND PEPTIDES Feb 28, 2022 Abandoned
Array ( [id] => 19275493 [patent_doc_number] => 12025616 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-02 [patent_title] => Method and composition for detection of proteolytic products and diagnosis of malignant neoplastic disease [patent_app_type] => utility [patent_app_number] => 17/679493 [patent_app_country] => US [patent_app_date] => 2022-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6854 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679493 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/679493
Method and composition for detection of proteolytic products and diagnosis of malignant neoplastic disease Feb 23, 2022 Issued
Array ( [id] => 19608891 [patent_doc_number] => 12157757 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-03 [patent_title] => Cation exchange chromatography methods [patent_app_type] => utility [patent_app_number] => 17/679640 [patent_app_country] => US [patent_app_date] => 2022-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5399 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679640 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/679640
Cation exchange chromatography methods Feb 23, 2022 Issued
Array ( [id] => 18583249 [patent_doc_number] => 20230265509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => NOVEL TARGETS FOR THE TREATMENT AND DIAGNOSIS OF PATIENTS WITH ATHEROSCLEROSIS AND ENHANCED RISK OF END ORGAN DAMAGE [patent_app_type] => utility [patent_app_number] => 17/676072 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18412 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676072 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/676072
NOVEL TARGETS FOR THE TREATMENT AND DIAGNOSIS OF PATIENTS WITH ATHEROSCLEROSIS AND ENHANCED RISK OF END ORGAN DAMAGE Feb 17, 2022 Abandoned
Array ( [id] => 17628525 [patent_doc_number] => 20220163540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => DETECTION OF GLUCURONIDATED AND 3-BROMOTYROSINE [patent_app_type] => utility [patent_app_number] => 17/668261 [patent_app_country] => US [patent_app_date] => 2022-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7347 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17668261 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/668261
Detection of glucuronidated and 3-bromotyrosine Feb 8, 2022 Issued
Array ( [id] => 19014184 [patent_doc_number] => 11921108 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-05 [patent_title] => Methods for determining amount of functional albumin [patent_app_type] => utility [patent_app_number] => 17/667376 [patent_app_country] => US [patent_app_date] => 2022-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 10218 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667376 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/667376
Methods for determining amount of functional albumin Feb 7, 2022 Issued
Array ( [id] => 20273050 [patent_doc_number] => 12442826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-14 [patent_title] => Lateral flow test strip readers, cartridges and related methods [patent_app_type] => utility [patent_app_number] => 17/590325 [patent_app_country] => US [patent_app_date] => 2022-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 22 [patent_no_of_words] => 11109 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590325 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/590325
Lateral flow test strip readers, cartridges and related methods Jan 31, 2022 Issued
Array ( [id] => 19021316 [patent_doc_number] => 20240077487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-07 [patent_title] => METHOD FOR THE DETECTION OF LUNG CANCER [patent_app_type] => utility [patent_app_number] => 18/261392 [patent_app_country] => US [patent_app_date] => 2022-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10245 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261392 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/261392
METHOD FOR THE DETECTION OF LUNG CANCER Jan 12, 2022 Abandoned
Array ( [id] => 18903946 [patent_doc_number] => 20240019431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => AUTOANTIBODIES AS BIOMARKERS FOR LIPODYSTROPHY [patent_app_type] => utility [patent_app_number] => 18/251926 [patent_app_country] => US [patent_app_date] => 2021-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15170 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251926 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/251926
AUTOANTIBODIES AS BIOMARKERS FOR LIPODYSTROPHY Dec 21, 2021 Pending
Array ( [id] => 18686336 [patent_doc_number] => 11782065 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-10 [patent_title] => Kits and methods for prediction and treatment of preeclampsia [patent_app_type] => utility [patent_app_number] => 17/558248 [patent_app_country] => US [patent_app_date] => 2021-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 8852 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558248 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/558248
Kits and methods for prediction and treatment of preeclampsia Dec 20, 2021 Issued
Array ( [id] => 18973269 [patent_doc_number] => 20240053361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => USE OF ALARMINS AS BIOMARKERS FOR ASSESSING ISCHEMIA-REPERFUSION INJURY SEVERITY AFTER SOLID ORGAN TRANSPLANTATION [patent_app_type] => utility [patent_app_number] => 18/257697 [patent_app_country] => US [patent_app_date] => 2021-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5335 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18257697 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/257697
USE OF ALARMINS AS BIOMARKERS FOR ASSESSING ISCHEMIA-REPERFUSION INJURY SEVERITY AFTER SOLID ORGAN TRANSPLANTATION Dec 13, 2021 Abandoned
Array ( [id] => 20757670 [patent_doc_number] => 12650434 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-06-09 [patent_title] => Methods of monitoring inflammatory bowel diseases [patent_app_type] => utility [patent_app_number] => 18/266497 [patent_app_country] => US [patent_app_date] => 2021-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9293 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266497 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/266497
Methods of monitoring inflammatory bowel diseases Dec 9, 2021 Issued
Array ( [id] => 19068593 [patent_doc_number] => 20240103019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => USE OF THE EMM ANTIGEN AS A BIOMARKER OF INHERITED GPI DEFICIENCIES [patent_app_type] => utility [patent_app_number] => 18/256453 [patent_app_country] => US [patent_app_date] => 2021-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6580 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256453 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/256453
USE OF THE EMM ANTIGEN AS A BIOMARKER OF INHERITED GPI DEFICIENCIES Dec 7, 2021 Pending
Array ( [id] => 18956586 [patent_doc_number] => 20240044913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => METHOD FOR MEASUREMENT OF CELL FREE NUCLEOPROTEIN CHROMATIN FRAGMENTS [patent_app_type] => utility [patent_app_number] => 18/253768 [patent_app_country] => US [patent_app_date] => 2021-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9269 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253768 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/253768
METHOD FOR MEASUREMENT OF CELL FREE NUCLEOPROTEIN CHROMATIN FRAGMENTS Nov 24, 2021 Pending
Array ( [id] => 17674160 [patent_doc_number] => 20220187327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => ASSAYS FOR DETECTING THE PRESENCE OR AMOUNT OF AN ANTI-DRUG ANTIBODY [patent_app_type] => utility [patent_app_number] => 17/534012 [patent_app_country] => US [patent_app_date] => 2021-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12785 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17534012 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/534012
Assays for detecting the presence or amount of an anti-drug antibody Nov 22, 2021 Issued
Array ( [id] => 18981364 [patent_doc_number] => 11906528 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-20 [patent_title] => Kits and methods to distinguish false labor and true labor [patent_app_type] => utility [patent_app_number] => 17/525717 [patent_app_country] => US [patent_app_date] => 2021-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 11226 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525717 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/525717
Kits and methods to distinguish false labor and true labor Nov 11, 2021 Issued
Array ( [id] => 19433867 [patent_doc_number] => 20240302365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => METHOD FOR DIAGNOSING CHRONIC URTICARIA [patent_app_type] => utility [patent_app_number] => 18/255680 [patent_app_country] => US [patent_app_date] => 2021-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3502 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255680 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/255680
METHOD FOR DIAGNOSING CHRONIC URTICARIA Nov 11, 2021 Abandoned
Menu